A study for a 62 year old woman who takes Aeroseb-Dex, Parafon Forte Dsc - from FDA reports

Summary

9 females aged 62 (±5) who take the same drugs are studied. This is a personalized study for a 62 year old female patient who has Pain - Back. The study is created by eHealthMe based on reports from FDA.



How the study uses the data?

The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered.

What are the drugs?

What are the conditions?

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 14, 2019

9 females aged 62 (±5) who take Aeroseb-Dex, Parafon Forte Dsc are studied.


Number of reports submitted per year:

Aeroseb-Dex, Parafon Forte Dsc for a 62-year old woman.

Information of the patient in this study:

  • Age: 62
  • Gender: female
  • Conditions: Pain - Back
  • Drugs taken:
    • Aeroseb-Dex (dexamethasone)
    • Parafon Forte Dsc (chlorzoxazone)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
  1. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen)
  2. Aspartate aminotransferase increased
  3. Malignant neoplasm progression (cancer tumour came back)
  4. Blood glucose increased
  5. Fibrin d dimer increased
  6. Blood alkaline phosphatase increased
1 - 6 months:
n/a
6 - 12 months:
n/a
1 - 2 years:
n/a
2 - 5 years:
n/a
5 - 10 years:
n/a
10+ years:
n/a
not specified:
  1. Fibrin d dimer increased
  2. Drug ineffective
  3. Aspartate aminotransferase increased
  4. Malignant neoplasm progression (cancer tumour came back)
  5. Lymphadenopathy mediastinal (an enlargement of the lymph nodes in the part of the chest that separates the lungs)
  6. Blood glucose increased
  7. Blood alkaline phosphatase increased
  8. Hypersensitivity
  9. Ischaemic stroke (stroke; caused by an interruption in the flow of blood to the brain)
  10. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen)

Top conditions involved for these people *:

  1. Leiomyosarcoma Metastatic (a very rare soft tissue sarcoma (cancer) that grows in muscle tissue spreading to other parts): 7 people, 77.78%
  2. Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 6 people, 66.67%
  3. Chemotherapy : 2 people, 22.22%
  4. Leiomyosarcoma (a very rare soft tissue sarcoma (cancer) that grows in muscle tissue): 1 person, 11.11%

Top co-used drugs for these people *:

  1. Zetia (7 people, 77.78%)
  2. Zestril (7 people, 77.78%)
  3. Ondansetron (7 people, 77.78%)
  4. Acetaminophen (6 people, 66.67%)
  5. Toprol-Xl (6 people, 66.67%)
  6. Palonosetron (6 people, 66.67%)
  7. Paclitaxel (6 people, 66.67%)
  8. Carboplatin (6 people, 66.67%)
  9. Aprepitant (6 people, 66.67%)
  10. Lorazepam (6 people, 66.67%)

* Some reports may have incomplete information.

What is next?

You are not alone:


Related publications that referenced our studies



Related studies:



FDA reports used in this study



Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.